Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 61 Breast Neoplasms 48 Myelodysplastic Syndromes 25 Neoplasms 23 Advanced Solid Tumor 23 Carcinoma, Non-Small-Cell Lung 21 Advanced Solid Tumors 21 Prostatic Neoplasms 20 Stomach Neoplasms 18 Recurrence 17 Carcinoma, Hepatocellular 17 Multiple Myeloma 16 Neoplasm Metastasis 15 Leukemia, Myelomonocytic, Chronic 13 Solid Tumor 12 Pancreatic Neoplasms 12 Ovarian Neoplasms 12 Lung Neoplasms 12 Uterine Cervical Neoplasms 10 Melanoma 10 Lymphoma, Large B-Cell, Diffuse 10 Sarcoma 9 Triple Negative Breast Neoplasms 8 Small Cell Lung Carcinoma 8 Myeloproliferative Disorders 8 Colorectal Neoplasms 8 Lymphoma, B-Cell 7 Esophageal Neoplasms 7 Biliary Tract Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6

Interventions

Pemetrexed 35 Cisplatin 30 pembrolizumab 19 Nivolumab 15 Carboplatin 15 Ipilimumab 11 Gemcitabine 9 Cyclophosphamide 7 durvalumab 6 fludarabine 5 Bevacizumab 5 Radiotherapy, Intensity-Modulated 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 olaparib 3 niraparib 3 anetumab ravtansine 3 Vinorelbine 3 Paclitaxel 3 LMB-100 3 Imatinib Mesylate 3 Fluorouracil 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 fludarabine phosphate 2 defactinib 2 budigalimab 2 belinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04996017 2025-03-13

AtezoMeso

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 3 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡